APT Pharmaceuticals
Pharmaceuticals - Burlingame, California, United States
APT Pharmaceuticals Employees
APT Pharmaceuticals Senior Management
APT Pharmaceuticals Details
APT Pharmaceuticals is focused on the development of cyclosporine inhalation solution (CIS) for the prevention and treatment of chronic rejection in lung transplantation. The company has successfully enrolled a large, multi-center Phase III clinical trial evaluating the effect of CIS on chronic rejection and is preparing for commercialization of the product in the US and Europe.
Website:
aptbio.com
Employees:
11 - 50
HQ:
Location:
Burlingame, California, United States
Revenue:
APT Pharmaceuticals Technologies
Hosting
Amazon AWS